Cancer Therapies
The latest news about Cancer Therapies: headlines, AI summaries and the full story from every source.
- Goldman Sachs Resumes Coverage of Iovance Biotherapeutics with Buy Rating
- Bristol-Myers Squibb Reports Better-than-Expected Q2 2026 Financials
- Pfizer and Innovent Biologics Announce $10.5 Billion Collaboration to Develop Cancer Therapies
- Hedge Fund Siren Adds $29 Million in Erasca Shares Despite Stock's 700% Surge
- H.C. Wainwright Upgrades Adlai Nortye's Price Target Amid Positive Outlook on Lead Asset